John Michael Pagel MD PHD
Hematologist-Oncologist | Hematology & Oncology
University Of Washington Medical Ctr 1959 Ne Pacific St Seattle WA, 98195About
Dr. John Pagel is a hematologist oncologist practicing in Seattle, WA. Dr. Pagel specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Boston Univ Sch of Med, Boston Ma 1996
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
- Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism.
- DNA topology-mediated regulation of transcription initiation from the tandem promoters of the ilvGMEDA operon of Escherichia coli.
- Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.
- A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
- Integration host factor-mediated expression of the ilvGMEDA operon of Escherichia coli.
- Pretargeted radioimmunotherapy for B-cell lymphomas.
- Radioimmunotherapeutic approaches for leukemia: the past, present and future.
- Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
- Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
- Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
- Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantation.
- Pretargeted radioimmunotherapy for hematologic and other malignancies.
- HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.
- Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.
Clinical Trials
John Michael Pagel MD PHD's Practice location
John Michael Pagel MD PHD's reviews
Write ReviewPatient Experience with Dr. Pagel
Recommended Articles
- Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission
4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
- This New Zealand Native Beat Cancer Eight Times
Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
- Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey
While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...
Nearby Providers
- Dr. Nicole Kuderer M.D.825 Eastlake Ave E Seattle WA 98109
- Dr. Cynthia Chua MD1354 Aloha St Seattle WA 98109
- Dr. Sheldon Z Goldberg MD515 Minor Ave Seattle WA 98104
- Dr. Sharmila Ahmed MD1101 MADISON ST SEATTLE WA 98104
- Dr. Elena G Chiorean M.D.825 EASTLAKE AVE E SEATTLE WA 98109
- Dr. Vincent J Picozzi MD1100 9th Ave Seattle WA 98101